Large-scale testing (Phase 3)Study completedNCT00240266
What this trial is testing
Study of High Density Lipoprotein Cholesterol (HDL-C)-Raising Mechanism of Rosuvastatin (CRESTOR™) by Quantifying the Key Steps of Reverse Cholesterol Transport (RCT)
Who this might be right for
Metabolic SyndromeDyslipidemia
AstraZeneca 15